Entry
Name
Condoliase (JAN/USAN/INN); Chondroitinase ABC; Hernicore (TN)
Formula
C5039H7770N1360O1525S22
Exact mass
112438.6115
Mol weight
112507.2381
Sequence
ATSNPAFDPK NLMQSEIYHF AQNNPLADFS SDKNSILTLS DKRSIMGNQS LLWKWKGGSS FTLHKKLIVP TDKEASKAWG RSSTPVFSFW LYNEKPIDGY LTIDFGEKLI STSEAQAGFK VKLDFTGWRA VGVSLNNDLE NREMTLNATN TSSDGTQDSI GRSLGAKVDS IRFKAPSNVS QGEIYIDRIM FSVDDARYQW SDYQVKTRLS EPEIQFHNVK PQLPVTPENL AAIDLIRQRL INEFVGGEKE TNLALEENIS KLKSDFDALN IHTLANGGTQ GRHLITDKQI IIYQPENLNS QDKQLFDNYV ILGNYTTLMF NISRAYVLEK DPTQKAQLKQ MYLLMTKHLL DQGFVKGSAL VTTHHWGYSS RWWYISTLLM SDALKEANLQ TQVYDSLLWY SREFKSSFDM KVSADSSDLD YFNTLSRQHL ALLLLEPDDQ KRINLVNTFS HYITGALTQV PPGGKDGLRP DGTAWRHEGN YPGYSFPAFK NASQLIYLLR DTPFSVGESG WNNLKKAMVS AWIYSNPEVG LPLAGRHPFN SPSLKSVAQG YYWLAMSAKS SPDKTLASIY LAISDKTQNE STAIFGETIT PASLPQGFYA FNGGAFGIHR WQDKMVTLKA YNTNVWSSEI YNKDNRYGRY QSHGVAQIVS NGSQLSQGYQ QEGWDWNRMQ GATTIHLPLK DLDSPKPHTL MQRGERGFSG TSSLEGQYGM MAFDLIYPAN LERFDPNFTA KKSVLAADNH LIFIGSNINS SDKNKNVETT LFQHAITPTL NTLWINGQKI ENMPYQTTLQ QGDWLIDSNG NGYLITQAEK VNVSRQHQVS AENKNRQPTE GNFSSAWIDH STRPKDASYE YMVFLDATPE KMGEMAQKFR ENNGLYQVLR KDKDVHIILD KLSNVTGYAF YQPASIEDKW IKKVNKPAIV MTHRQKDTLI VSAVTPDLNM TRQKAATPVT INVTINGKWQ SADKNSEVKY QVSGDNTELT FTSYFGIPQE IKLSPLP
Type
Peptide
Source
Proteus vulgaris [TAX:
585 ]
Remark
Therapeutic category: 3999
Efficacy
Lumbar disc herniation treatment, Proteoglycan modulator
Comment
GAG (glycosaminoglycan) catabolic enzyme [EC:
4.2.2.20 ]
Treatment of lumbar disc herniation
Brite
Therapeutic category of drugs in Japan [BR:br08301 ]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D09800 Condoliase (JAN/USAN/INN)
New drug approvals in Japan [br08318.html ]
Drugs with new active ingredients
D09800
New drug approvals in the USA, Europe and Japan [br08328.html ]
Approval dates by FDA, EMA and PMDA
D09800
BRITE hierarchy
Other DBs
LinkDB
All DBs